Seeking Alpha

BiotechMoney18's  Instablog

Send Message
Biotech & trend trader. Follow me twitter @BiotechMoney18 for more trade ideas.
  • Cyclacel Pharmaceuticals, Inc (CYCC) Undervalued With Upside 20-50% From Here 1 comment
    Jul 30, 2013 9:57 AM | about stocks: CYCC

    If you follow me closely on Twitter you would have make plenty of money from the recent pop ideas: PRAN from 2.20, NSPR from 2.10, IMUC from 2.20, and ARWR from 1.90. They all range from 20-55% gains. I would like to take this opportunity to share with you the next pop ideas.

    CYCC, I believe this company currently trading at $3.20ish could provide a high value movement up to $3.82-$4 in short to mid term.

    Reasons to be bullish:

    1. Insider buy: On May 22nd CEO bought 100,000 @ $3 and again on May 24th 100,000 @ $3. Director and CFO also bought shares on May 22nd 33,333 and 12,983 sharres, respectively. Watch what happened to SNTA yesterday pop on insider bought at $5ish.
    2. Deep pipeline with Sapacitabine: AML, MDS, NSCLC With Orphan designation in US & EU for both AML and MDS.
    3. Already refinance at
    4. MDS data P2 single agent median survival of ~9 months nearly doubled expected median survival in HMA failures. With their fully published data is due soon.
    5. BRCA
    6. Debt free and low floater.

    Some Key Milestones from their Jul 10 JMP conf


    - SEAMLESS Phase 3 enrollment update

    - Next periodic DSMB review of SEAMLESS

    -Updated Phase 2 survival data in MDS after HMAs

    -Update Phase 1 data Sapacitabine $ Seliciclib in patients with solid tumors

    - Announce registration plan for MDS after HMAs

    Reason to be bearish:


    Disclosure: I am long CYCC.

    Additional disclosure: I wrote this article myself, and my opinions. I am not receiving compensation for it. I have no business relationship with any company whose stock is mentioned in this article. This article is intended for informational and entertainment use only. Always do your due diligence before buying.

    Themes: ARWR, IMUC, PRAN, NSPR Stocks: CYCC
Back To BiotechMoney18's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (1)
Track new comments
  • barleyhouse
    , contributor
    Comments (2) | Send Message
    Not sure if you read this article. wanted to pass it along.
    31 Dec 2013, 08:05 AM Reply Like
Full index of posts »
Latest Followers


More »

Latest Comments

Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.